| Literature DB >> 6781935 |
K Koike, T Aono, A Miyake, H Tsutsumi, K Matsumoto, K Kurachi.
Abstract
Bromocriptine is known to be effective in the treatment of women with hyperprolactinemic anovulation or amenorrhea-galactorrhea. A new schedule of combined treatment with bromocriptine and clomiphene citrate was applied to 23 patients with normoprolactinemic amenorrhea who failed to respond to clomiphene alone. Ovulation was restored by treatment in 14 of these patients (60.9%), resulting in pregnancy in 3 women. Treatment resulted in immediate suppression of serum prolactin levels and a gradual increase in serum luteinizing hormone levels and estradiol levels followed by a luteinizing hormone surge. The present results indicate that bromocriptine/clomiphene combination therapy is effective in the treatment of amenorrheic patients with normoprolactinemia who do not respond to clomiphene alone, and suggest that bromocriptine restores the responsiveness of the hypothalamic-pituitary-ovarian system to clomiphene.Entities:
Keywords: Adrenal Cortex Hormones--administraction and dosage; Amenorrhea; Biology; Clomiphene--administraction and dosage; Diseases; Endocrine System; Estradiol--analysis; Estrogens; Family Planning; Fertility Agents; Follicle Stimulating Hormone--analysis; Gonadotropins; Gonadotropins, Pituitary; Hormones; Luteinizing Hormone--analysis; Menstruation; Menstruation Disorders; Physiology; Pituitary Hormones; Population Characteristics; Progestational Hormones; Progesterone--analysis; Prolactin--analysis; Reproductive Control Agents; Treatment
Mesh:
Substances:
Year: 1981 PMID: 6781935 DOI: 10.1016/s0015-0282(16)45312-4
Source DB: PubMed Journal: Fertil Steril ISSN: 0015-0282 Impact factor: 7.329